 Alzheimer Disease
"Alzheimer Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Descriptor ID |
D000544
|
| MeSH Number(s) |
C10.228.140.380.100 C10.574.945.249 F03.615.400.100
|
| Concept/Terms |
Alzheimer Disease- Alzheimer Disease
- Alzheimer's Disease
- Dementia, Senile
- Senile Dementia
- Dementia, Alzheimer Type
- Alzheimer Type Dementia
- Alzheimer-Type Dementia (ATD)
- Alzheimer Type Dementia (ATD)
- Dementia, Alzheimer-Type (ATD)
- Alzheimer Type Senile Dementia
- Primary Senile Degenerative Dementia
- Dementia, Primary Senile Degenerative
- Alzheimer Sclerosis
- Sclerosis, Alzheimer
- Alzheimer Syndrome
- Alzheimer Dementia
- Alzheimer Dementias
- Dementia, Alzheimer
- Dementias, Alzheimer
- Senile Dementia, Alzheimer Type
Familial Alzheimer Disease (FAD)- Familial Alzheimer Disease (FAD)
- Alzheimer Disease, Familial (FAD)
- Alzheimer Diseases, Familial (FAD)
- Familial Alzheimer Diseases (FAD)
|
Below are MeSH descriptors whose meaning is more general than "Alzheimer Disease".
Below are MeSH descriptors whose meaning is more specific than "Alzheimer Disease".
This graph shows the total number of publications written about "Alzheimer Disease" by people in this website by year, and whether "Alzheimer Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 | | 1997 | 4 | 1 | 5 | | 1998 | 7 | 0 | 7 | | 1999 | 2 | 1 | 3 | | 2000 | 6 | 1 | 7 | | 2001 | 4 | 2 | 6 | | 2002 | 3 | 1 | 4 | | 2003 | 8 | 0 | 8 | | 2004 | 5 | 1 | 6 | | 2005 | 12 | 4 | 16 | | 2006 | 8 | 4 | 12 | | 2007 | 19 | 4 | 23 | | 2008 | 12 | 2 | 14 | | 2009 | 10 | 2 | 12 | | 2010 | 18 | 3 | 21 | | 2011 | 11 | 3 | 14 | | 2012 | 14 | 7 | 21 | | 2013 | 7 | 3 | 10 | | 2014 | 10 | 2 | 12 | | 2015 | 18 | 3 | 21 | | 2016 | 16 | 5 | 21 | | 2017 | 13 | 3 | 16 | | 2018 | 9 | 3 | 12 | | 2019 | 14 | 5 | 19 | | 2020 | 20 | 4 | 24 | | 2021 | 23 | 6 | 29 | | 2022 | 40 | 0 | 40 | | 2023 | 35 | 2 | 37 | | 2024 | 16 | 5 | 21 | | 2025 | 25 | 6 | 31 | | 2026 | 5 | 4 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Alzheimer Disease" by people in Profiles.
-
Di Domenico F, Perluigi M, Tramutola A, Bacalini MG, Balduino Victorino D, Barroeta I, Bartesaghi R, Carfi A, Carmona-Iragui M, Cohen AD, Costa ACS, Costanzo F, Dierssen M, Dunn L, Emili M, Evans EJ, Farrell C, Flores-Aguilar L, Fukami-Gartner A, Gimenez S, Granholm AC, Hilgenkamp T, Izzo A, Krinsky-McHale SJ, Del Hoyo Soriano L, Meijer L, Mobley B, Moskowitz IP, Nizetic D, Pierce J, Ptomey LT, Rachubinski AL, Rebillat AS, Roper R, Santoro JD, Skotko BG, Stagni F, Strydom A, Valay L, Zaman S, Zampieri BL, Potier MC, Barone E. Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society. Neuromolecular Med. 2026 06 06; 28(1).
-
Jarvis I, Besser L, Finlay J, Hystad P, Lane KJ, Hunter RF, James P, Jiménez MP, Nieuwenhuijsen M, van den Bosch M, Van Riper D, Lee J, Doiron D, Brook J, Adar SD, Brauer M. Urban greenspace and dementia: Measures, mechanisms, and methodological guidance. Alzheimers Dement. 2026 Jun; 22(6):e71557.
-
Bettcher BM, Ren S, Wang Y, Carlson NE, Lippitt WL, McConnell BV, Wilson EN, Shapiro ALB, Coughlan C, Carlisle TC, Unger JR, Cook GG, Bengtson K, Gorla L, Ueberheide BM, Kanshin E, Potter H, Schulz L, Frazer-Abel A, Pelak VS. Relation of blood-based inflammation conditional networks to key immune health status and Alzheimer's biomarkers in aging adults. Neurobiol Aging. 2026 Oct; 166:14-28.
-
Yang M, Abdulsalam R, Shi Y, Fan W, Manson SM, Corrada MM, O'Connell J, Jiang L. Alzheimer's disease and related dementias and related health conditions among American Indian and Alaska Native Medicare beneficiaries. Alzheimers Dement. 2026 Apr; 22(4):e71385.
-
Rae RJ, Alberhasky JMH, Baillet M, Bangasser DA, Belloy ME, Berry AS, Berteotti C, Bow H, Buckley R, Caldwell JZK, Carpi M, Clark BJ, Ciampa CJ, Conley AC, Dahl MJ, Donaldson ZR, Ehrenberg AJ, Einstein G, Falgàs N, Fenlon HA, Fitzhugh MC, Froemke RC, Gallay C, Grinberg LT, Hamilton DA, Hasan Z, Huarte OU, Jabeen S, Jacobs HIL, Kolling LJ, Koops EA, Lenzoni S, Liguori C, Manca R, Marcinkiewcz CA, Omoluabi T, Oria R, Orsini CA, Ortega NE, Pa J, Pentkowski NS, Pereira JB, Ramos R, Sargin D, Satpati A, Selles MC, Seto M, Shaik SM, Sindi S, Son G, Ucheagwu V, Van Egroo M, Yuan Q, Kelberman MA. Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease. Alzheimers Dement. 2026 Mar; 22(3):e71291.
-
Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. Alzheimers Dement. 2026 Feb; 22(2):e71067.
-
Keleman AA, Li M, Wisch JK, Bollinger RM, Krauss MJ, Grant EA, Benzinger TLS, Ances BM, Morris JC, Stark SL. Falls predict faster progression to Alzheimer's dementia. Alzheimers Dement. 2026 Feb; 22(2):e71177.
-
Heo RJ, Negida A, Barrett MJ, Chrenka EA, Bayram E, Kane JPM, Werner AM, Rossom RC, Wyman-Chick KA. Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. J Alzheimers Dis. 2026 Feb; 109(4):1917-1924.
-
Arias JJ, Nielsen KE, Bolcic-Jankovic D, Bonham LW, Campbell EG, Lah JJ, Manchester MA, Scipion CEA, Wang Y, Wolf LE, Mello MM, Yokoyama JS. Data sharing practices and experiences among Alzheimer's disease and related dementia researchers. Alzheimers Dement. 2026 Jan; 22(1):e71046.
-
Bellver-Sanchis A, Valle-Garcia D, Barbaraci C, Romero-Becerra F, Singh RK, Jarne-Ferrer J, Vasilopoulou F, Irisarri A, Martínez-Fernández C, Fafián-Labora JA, Arufe MC, Wüst C, Castellanos A, Soto D, Casals N, Fadó R, Pocock JM, Navarro G, Val C, Brea J, Loza MI, Lleó A, Fortea J, Alcolea D, Perez-Bosque A, Miró L, Pérez B, Rashid S, Ali M, Saqib M, Lí Carbó M, Guerrero A, Vázquez S, Choudhary BS, Dai S, Escolano C, Franco R, Pallàs M, Griñán-Ferré C. First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease. Mol Ther. 2026 Apr 01; 34(4):2372-2407.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|